Director Global Health Economics and Outcomes Research

Location: Barcelona, Spain (on - site) 3 days working from the office and 2 days working from home

The Director, Global Health Economics and Outcomes Research (GHEOR) leads the strategic development and execution of health economics and outcomes research strategies to support the worldwide launch and reimbursement of products across a range of disease areas.   This particular role would lead the Real World Evidence and Patient Reported Outcomes as a Center of Excellence to promote capabilities within the Rare Disease portfolio to bring leadership, efficiency and impact to patients with rare disease.

Through key leadership and partnership across cross-functional teams, the job holder enables RWE and PRO strategy to be embedded into broader disease area and clinical development strategies via the therapeutic area leaders. This collaboration builds strategies to demonstrate and differentiate the value proposition and corresponding scientific evidence of Alexion products for payers, patients, clinical institutions, and other key influencers. The Director, Global HEOR partners with and provides  leadership to HEOR/Medical, Market Access, Clinical Development, and Commercial teams as well as regions and countries.  This role reports directly to the Senior Director EUCAN & International Head HEOR.

You will be responsible for:

Utilizes in-depth knowledge of disease area and portfolio strategy in combination with health economics and outcomes research to develop and build capabilities for RWE and PRO. Ensures patient and stakeholder relevant endpoints and evidence generation strategies are implemented throughout the product lifecycle.

• Builds collaborative relationships with cross-functional leaders across Medical, Research & Development, Commercial, Market Access organizations to maximize evidence generation efforts to optimize launch and sustained reimbursement throughout the product lifecycle
• Partners with the Therapeutic Area (TA) heads and Regional/Country teams to develop TA business strategies and clinical development plans that will provide a competitive advantage to differentiated patient relevant evidence; drives efficient and innovative HEOR study development and study execution and dissemination.
• Continually monitors the global marketplace for market access issues, identifies access/demand hurdles, and creates plans to demonstrate the value and differentiation of assets within the therapeutic area portfolio
• Ensures Alexion maintains external credibility and relationships to validate research findings and communications.
• Cultivates and maintains relationships with key experts, influencers, and customer segments to foster and maintain Alexion’s credibility to support the value and reimbursement of Alexion products
• Delivers presentations on behalf of Alexion at various industry and scientific forums and/or contribute to publications
• Maintains the relationship with external agencies and monitors their performance to ensure that performance and deliverables meet business expectations
• Contributes to the global HEOR infrastructure to provide direction and guidance to Regional HEOR and Country Medical teams.

• Develops best practices in HEOR including approaches to areas including research methodologies, study designs, endpoints that provide scientifically sound protocols, policies, tools, and outcome impact.
• Provides global oversight and guidance to country teams to adapt the global strategies into tactical plans through robust Health Technology Assessment processes to achieve optimal access and sustained reimbursement throughout the product lifecycle
• Identify areas for process improvements, economies of scale, and other quality, and efficiency measures

You will need to have:

• PhD or equivalent combination of education and experience
• 10+ years prior experience in HEOR, RWE or Epidemiology in the biopharmaceutical/pharmaceutical industry
• Thorough understanding of the field of Health Technology Assessment at a global level and experience of successful negotiations through the HTA processes
• Extensive experience in RWE, both prospective and retrospective observational research.
• Expertise in PRO development, assessment, validation and providing guidance on inclusion of PRO instruments in clinical trials.   
• Understanding of the global market access landscape and environment
• Knowledge of the drug development and commercialization process
• Recognized as a strong leader with a proven track record of effectively managing, influencing, and developing people including those who are not direct reports: demonstrated ability to lead and deliver results in a matrix environment, and solve complex issues that cross multiple stakeholders
• Excellent interpersonal skills with a track record of effectiveness as a team player; excellent oral/written communication, and presentation skills
• Excellent project leader who can effectively manage multiple competing priorities to completion
• Global mindset and ability to work with multicultural teams
• Flexibility and adaptability to internal and external change
• Fluent in English

We would prefer for you to have:

• Experience and knowledge in rare disease conditions

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.